Contrast Induced Nephropathy: Clinical Trials

6 trials for Contrast Induced Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown. 6 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Recruiting 1, Unknown 1
Phase 33Completed 2, Recruiting 1

Follow Contrast Induced Nephropathy: new trials by email Literature Review of Contrast Induced Nephropathy trials Research Report on Contrast Induced Nephropathy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Remote ischemic preconditioning, Sham remote ischemic conditioning - Acute Kidney Injury, Heart Failure
Phase 2 / Phase 3RecruitingVA Office of Research and Development2402021-11-012025-12-15
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
sodium bicarbonate, Acetazolamide, normal salin - Contrast Induced Nephropathy
Phase 2CompletedShiraz University of Medical Sciences2402007-09-012008-03-13
Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN
Sodium Bicarbonate - Contrast Induced Nephropathy
Phase 2CompletedTehran University of Medical Sciences722007-08-012008-11-26
COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT
N-acetylcysteine, Sodium Bicarbonate - Contrast Induced Nephropathy
Phase 2 / Phase 3CompletedNational University Hospital, Singapore4772007-08-012014-01-14
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
3 amps of sodium bicarbonate mixed in one liter of D5W - Contrast Induced Nephropathy
Phase 2UnknownNorton Community Hospital6562006-11-012006-10-26
N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography
N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill
Phase 2 / Phase 3CompletedUnity Health Toronto452002-08-012009-01-27

Narrower conditions

Acute Coronary Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Coronary Artery Disease (1)  ·  Critical Illness (1)  ·  Heart Failure (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Myocardial Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)

Interventions

Sodium Bicarbonate (3)  ·  Acetylcysteine (2)  ·  Acetazolamide (1)

Sponsors

National University Hospital, Singapore (1)  ·  Norton Community Hospital (1)  ·  Shiraz University of Medical Sciences (1)  ·  Tehran University of Medical Sciences (1)  ·  Unity Health Toronto (1)  ·  VA Office of Research and Development (1)

Countries

Iran (2)  ·  United States (2)  ·  Canada (1)  ·  Singapore (1)

Top investigators

Abbas Soleimani, M.D. (1)  ·  Ahmad Iaminisharif, M.D. (1)  ·  Akbar Fotuhi, M.D. (1)  ·  Ali Farahani Vasheghani, M.D. (1)  ·  Ali Kazemisaeid, M.D. (1)  ·  Alireza Amirzadegan, M.D. (1)  ·  Amir Hossein Razavi, M.D. (1)  ·  Claudio M Martin, MD, FRCPC, MSc (1)  ·  Donna S Sanders, DO (1)  ·  Ebrahim Kassaian, M.D. (1)  ·  Ebrahim Nematipur, M.D. (1)  ·  Gelareh Sadigh, M.D. (1)  ·  Gholamreza Davoodi, M.D. (1)  ·  Hamidreza Purhosseini,, M.D. (1)

Results publications

PMID 16391986, PMID 26301645

NIH funding

I01CX002045 (1)